On Demand Programme

ESSO 2020 VIRTUAL

Reshaping Surgical Oncology after COVID-19

Friday 23 October 2020, 16:00 - 21:00 CEST
Saturday 24 October 2020, 09:00 - 13:00 CEST

ORALS ON DEMAND PROGRAMME

FRIDAY 23 OCTOBER 2020 – SATURDAY 24 OCTOBER 2020


Breast cancer session I

  • ESSO20V-0171 - Long-term quality of life and aesthetic outcomes after breast conserving therapy in patients with breast cancer – Speaker: Marije Zwakman, NL
  • ESSO20V-0010 - Diagnostic performance of noninvasive imaging for assessment of axillary pathologic complete response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a meta-analysis – Speaker: Kees De Mooij, NL
  • ESSO20V-0022 - Physical performance of a RFID tag for surgical guidance in localizing non-palpable breast lesions – Speaker: Fleur Jacobs, NL
  • ESSO20V-0109 - A national multicenter randomized controlled trial to evaluate Closed Incision Negative Pressure Therapy in oncological breast surgery. – Speaker: Pietro Ferrando, IT

    Breast cancer session II

  • ESSO20V-0144 - Day case partial breast reconstructions with chest wall perforator flaps before and during the COVID-19 pandemic. – Speaker: Arwa Ashoor, UK
  • ESSO20V-0020 - Modified Radical Mastectomy Vs Breast Conserving Surgery: Current Clinical Practice in Women With Early Stage Breast Cancer At A Corporate Tertiary Cancer Center in India – Speaker: Sachin Kadam, IN
  • ESSO20V-0147 - The impact of neoadjuvant chemotherapy in biological subtype of breast cancer – Speaker: Paula Pinto, PT
  • ESSO20V-0153 - MRI Use and its Impact on Surgical Decision Making in Invasive Lobular Carcinoma of the Breast – Speaker: Emma Kearns, IE

Colorectal and anal cancer session I

  • ESSO20V-0105 - Current practice in Australia and New Zealand for defunctioning ileostomy after rectal cancer surgery with anastomosis: Analysis of the Bi-National Colorectal Cancer Audit (BCCA) – Speaker: Vera Grupa, AU
  • ESSO20V-0141 - Can prehabilitation protect frail colorectal cancer patients over 70 years old from complications after surgery? – Speaker: Heleen Van Der Hulst, NL
  • ESSO20V-0074 - Coagulopathy and Venous Thromboembolic Events Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy – Speaker: Paul Dranichnikov, SE
  • ESSO20V-0195 - Colorectal services in COVID-19 times: Minimally invasive surgery and Enhanced recovery is the need of hour – Speaker: Vivek Sukumar, IN
  • ESSO20V-0014 - Artificial intelligence for the diagnosis of lymph node metastases in patients with abdominopelvic malignancy: a systematic review and meta-analysis. – Speaker: Sergei Bedrikovetski, AU

    Colorectal and anal cancer session II

  • ESSO20V-0123 - Anastomotic leakage risk nomogram does not predict leakage accurately in all populations: Results of the international multi-center prospective LekCheck study – Speaker: Izel Ozmen, AU
  • ESSO20V-0199 - Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: the PelvEx II study – Speaker: Eva Voogt, NL
  • ESSO20V-0038 - TaTME vs laparoscopic TME: a comparative matched analysis – Speaker: Francesco Orlando, IT
  • ESSO20V-0037 - Risk factors for non-closure of an intended temporary defunctioning stoma after emergency resection of left-sided obstructive colon cancer – Speakers: Edgar Furnee, NL
  • ESSO20V-0030 - Rates of colorectal cancer/polyps detection in luminal investigations post appendicectomy in patients over 40 years – Speakers: Omotara Lesi, UK

Oesophageal and gastric cancer session

  • ESSO20V-0078 - Identification of key long-term symptoms and associated factors affecting quality of life after esophagectomy; multi-center European LASER study – Speaker: Sheraz Markar, UK
  • ESSO20V-0071 - Standard of Care and Survival for Signet-ring Cell and Non-Signet-ring Cell Gastric Cancer are More Achievable at Academic Cancer Centers – Speaker: Maitham Moslim, US
  • ESSO20V-0134 - Chemoradiotherapy followed by active surveillance versus standard surgery for oesophageal cancer: a systematic review and individual patient data meta-analysis – Speaker: Berend Van Der Wilk, NL
  • ESSO20V-0193 - Systemic chemotherapy including ramucirumab in combination with pressurized intra-peritoneal aerosol chemotherapy (PIPAC) is a safe treatment option for peritoneal metastasis of gastric cancer – Speaker: Linda Feldbrügge, DE
  • ESSO20V-0061 - Nomogram to Predict the Risk of Osteoporosis after Gastrectomy for Gastric Cancer – Speaker: Ki Bum Park, KR

Head & neck and thyroid cancer session

  • ESSO20V-0100 - Clinical application of circulating tumour DNA in assessment of therapeutic response in HPV positive oropharyngeal cancer – Speaker: Lucy Li, UK
  • ESSO20V-0092 - Magnetic sentinel lymph node biopsy procedure in oral cancer – Speaker: Barry Kolenaar, NL
  • ESSO20V-0072 - Parathyroid carcinoma: A population-based clinical outcomes study involving 609 patients from the Surveillance Epidemiology and End Result (SEER) database (1975–2016) – Speaker: Abdul Waheed, US
  • ESSO20V-0081 - Active surveillance for papillary thyroid microcarcinoma in the Netherlands – Speaker: Ivona Loncar, NL

Peritoneal carcinomatosis session

  • ESSO20V-0039 - Intraperitoneal aerosolization of albumin-bound paclitaxel nanoparticles (Abraxane®) for peritoneal metastasis: a phase I first-in-human study – Speaker: Leen Van de Sande, BE
  • ESSO20V-0093 - Debulking and HIPEC for ovarian cancer: effects of perfusion temperature on morbidity and cisplatin pharmacokinetics – Speaker: Jesse Demuytere, BE
  • ESSO20V-0127 - Cytoreductive Surgery and HIPEC: An audit of early early post-operative surgical re-intervention – Speakers: Niall Mcinerney, IE
  • ESSO20V-0015 - A retrospective study about the oncological outcome of pelvic exenteration in recurrent/residual cervical cancer – Speaker: Dharma Poonia, IN
  • ESSO20V-0137 - Electrostatic precipitation pressurized intraperitoneal aerosol chemotherapy (ePIPAC): Finding the optimal electrical potential – Speaker: Mohammad Rahimi Gorji, BE